Accuray Inc
NASDAQ:ARAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Accuray Inc
Interest Income Expense
Accuray Inc
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Accuray Inc
NASDAQ:ARAY
|
Interest Income Expense
-$16.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$369m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Interest Income Expense
$145.4m
|
CAGR 3-Years
68%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
-$486m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-24%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$148m
|
CAGR 3-Years
23%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$365.9m
|
CAGR 3-Years
131%
|
CAGR 5-Years
18%
|
CAGR 10-Years
35%
|
|
Accuray Inc
Glance View
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
See Also
What is Accuray Inc's Interest Income Expense?
Interest Income Expense
-16.8m
USD
Based on the financial report for Dec 31, 2025, Accuray Inc's Interest Income Expense amounts to -16.8m USD.
What is Accuray Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
3%
Over the last year, the Interest Income Expense growth was -177%. The average annual Interest Income Expense growth rates for Accuray Inc have been -9% over the past three years , 3% over the past five years .
